樂
樂觀
樂觀 · 25%DNA
$11.62
情境價格
$13.320
+2.423 (+18.19%)收盤時
Loading chart…
- 最高
- 13.670
- 開盤
- 11.160
- 成交量加權均價
- 12.72
- 成交量
- 3.78M
- 市值
- 683.73M
- 最低
- 11.160
- 成交金額
- 48.03M
- 企業價值/稅息折舊攤銷前利潤（TTM）
- -4.50
Ginkgo Bioworks Holdings, Inc. offers biological research and development (R&D) services on its platform and autonomous laboratory to enable its customers to bring their products to market. The Company sells tools and biological R&D services across a range of industries to government and commercial customers. Its in-house autonomous lab is available as Cloud Lab through its Datapoints and Solutions contract research services. Its single segment, namely cell engineering, provides tools and biological R&D services across a range of industries. Its cell engineering customers work with biology to discover and manufacture new products across industries such as medicine, agriculture, industrial biotechnology and government. It provides R&D services spanning genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics. It provides a suite of microservices for product developers across industries that support bioengineers with protein engineering.
AI 分析 of Ginkgo Bioworks Holdings Inc (DNA)
賣出Ginkgo Bioworks is not a good buy right now due to its significant financial struggles and negative market sentiment. The current price is $9.99, and the company reported a staggering net income loss of $46.7 million in Q2 2026, which is indicative of ongoing financial distress. Additionally, insider selling has surged by 74248.78%, raising concerns about confidence in the company's future.
分析師評級（2）
-9.91% 下跌空間
賣出
0 買進
0 持有
2 賣出
目前: 13.32
最低
12.00
平均
12.00
最高
12.00
TD Cowen
持有
$9
2026-08-07
TD Cowen
2026-08-07
目標價
$9
持有
BTIG
賣出
$5
2026-03-12
BTIG
2026-03-12
目標價
$5
賣出
TD Cowen
買進
$12
2026-01-08
TD Cowen
2026-01-08
目標價
$12
買進
BTIG
賣出
$9
2025-08-25
BTIG
2025-08-25
目標價
$9
賣出
TD Cowen
買進
$16
2025-08-08
TD Cowen
2025-08-08
目標價
$16
買進
估值指標
Ginkgo Bioworks Holdings Inc（DNA）目前預期本益比為 0.00，5 年平均預期本益比為 -6.20。
Alphio AI 對 DNA 的價格情境
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重（25 / 50 / 25），不構成保證。
持有 DNA 的大戶
事件時間軸
資訊
- 2.010-29Fool
Analysis of Archer Aviation's Stock Volatility
7.510-09PRnewswireGinkgo Integrates Araceli's High-Throughput Imaging Technology
7.510-08NewsfilterGinkgo Bioworks Supports NSF X-Labs Program with Autonomous Lab Access
7.510-08PRnewswireGinkgo Bioworks Integrates Araceli's High-Throughput Imaging Technology
7.510-08PRnewswireAraceli and Ginkgo Enhance Cellular Imaging Capabilities
DNA 常見問題 —— 由 Alphio AI 解答
Ginkgo Bioworks Holdings, Inc. offers biological research and development (R&D) services on its platform and autonomous laboratory to enable its customers to bring their products to market. The Company sells tools and biological R&D services across a range of industries to government and commercial customers. Its in-house autonomous lab is available as Cloud Lab through its Datapoints and Solutions contract research services. Its single segment, namely cell engineering, provides tools and biological R&D services across a range of industries. Its cell engineering customers work with biology to discover and manufacture new products across industries such as medicine, agriculture, industrial biotechnology and government. It provides R&D services spanning genetic medicine modalities: gene therapy, cell therapy and gene editing, and RNA therapeutics. It provides a suite of microservices for product developers across industries that support bioengineers with protein engineering. It operates in the Healthcare sector (BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry).
Ginkgo Bioworks is not a good buy right now due to its significant financial struggles and negative market sentiment. The current price is $9.99, and the company reported a staggering net income loss of $46.7 million in Q2 2026, which is indicative of ongoing financial distress. Additionally, insider selling has surged by 74248.78%, raising concerns about confidence in the company's future.
2 analysts cover DNA: 0 rate it Buy, 0 Hold and 2 Sell. The average price target is 12.00.
社群
更多 ↗
$RT1 $DOGE 🚨 DNA IS TESTING A MAJOR RESISTANCE...... A BREAKOUT COULD CHANGE THE PICTURE! 📈 $DNA Buyers have stepped back in, and RSI(6) near 55 suggests mildly bullish momentum. However, the recent rejection near $0.22011 shows that sellers are still defending higher prices. 📈 If buyers break above $0.22011 with strong volume, the price could move toward $0.23180. But if resistance holds and momentum fades, DNA may pull back toward $0.19120, with $0.17168 as the key support to watch. 👀 Key levels to watch: 🟢 Support: $0.19120 – $0.17168 🔴 Resistance: $0.22011 – $0.23180 ⚠️ Don’t mistake a bounce for a confirmed breakout. Wait for confirmation and always manage your risk. $DNA
展開
$DNA DUMPS 27% | BEARISH TARGET IN SIGHT My October 19 bearish setup on #DNA continues to play out, with price now down to $0.19074, a ~27% drop from our short setup's breakdown exit point. Updated Technical Analysis: ➤ Current Price: $0.19074 ➤ Bearish Target: $0.148 ➤ Key Resistance: $0.250 ➤ Bearish Outlook: Still watching for further downside toward $0.148. The chart is doing the talking. Hope you're enjoying the analysis. Stay tuned for the next update.
展開
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。